Hematology
Volume 27, 2022 - Issue 1
Open access
2,268
Views
0
CrossRef citations to date
0
Altmetric
Research Article
Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells
Jiangzhao Zhanga Department of Hematology, Jingzhou Central Hospital, Institute of Hematology, Yangtze University, Jingzhou, People’s Republic of ChinaView further author information
, Min Zhangb Department of Nephrology, Jingzhou Central Hospital, Jingzhou, People’s Republic of ChinaView further author information
, Yan Liangc Department of Hematology, Jingzhou Central Hospital, Jingzhou, People’s Republic of ChinaView further author information
, Min Liuc Department of Hematology, Jingzhou Central Hospital, Jingzhou, People’s Republic of ChinaView further author information
& Zhiping Huanga Department of Hematology, Jingzhou Central Hospital, Institute of Hematology, Yangtze University, Jingzhou, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-7165-9019View further author information
Pages 43-52
|
Published online: 27 Dec 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.